Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1Dermatologic 1

Conditions

Squamous Intraepithelial Lesions 1Keratosis, Actinic 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × calcipotriene × 1 year × Clear all
NCT03370406 2026-06-01

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

University of Pittsburgh

Phase 1 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT05381597 2025-11-28

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

Boston University

Phase 2/3 Recruiting
200 enrolled
Gynecologic

Squamous Intraepithelial Lesions

NCT05699603 2025-09-24

Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients

University of Arizona

Phase 2 Active not recruiting
56 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡